Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46000302BKPyvENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS10006802HBVENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS10013718HBVENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS10019065HBVENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS30075950HIVENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS30031224HIVENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS20049384HPVENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS20037252HPVENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44017262HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TVIS44026516HTLV-1ENSG00000152402.11protein_codingGUCY1A2NoNo2977P33402
TCGA Plot Options
Drug Information
GeneGUCY1A2
DrugBank IDDB08931
Drug NameRiociguat
Target IDBE0003578
UniProt IDP33402
Regulation Typeagonist
PubMed IDs22044316; 26219978
CitationsSoeiro-Pereira PV, Falcai A, Kubo CA, Oliveira-Junior EB, Marques OC, Antunes E, Condino-Neto A: BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes. Br J Pharmacol. 2012 Jul;166(5):1617-30. doi: 10.1111/j.1476-5381.2011.01764.x.@@Humbert M, Ghofrani HA: The molecular targets of approved treatments for pulmonary arterial hypertension. Thorax. 2016 Jan;71(1):73-83. doi: 10.1136/thoraxjnl-2015-207170. Epub 2015 Jul 28.
GroupsApproved
Direct ClassificationPyrazolopyridines
SMILESCOC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=C1C=CC=N2
Pathways
PharmGKB
ChEMBLCHEMBL2107834